News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
742,456 Results
Type
Article (44782)
Company Profile (244)
Press Release (697416)
Multimedia
Podcasts (108)
Webinars (23)
Section
Business (206164)
Career Advice (2339)
Deals (35875)
Drug Delivery (149)
Drug Development (82408)
Employer Resources (184)
FDA (16790)
Job Trends (15141)
News (349815)
Policy (33205)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2688)
Accelerated approval (55)
ADA (45)
Adcomms (33)
Allergies (194)
Alliances (49934)
ALS (231)
Alzheimer's disease (1876)
Antibody-drug conjugate (ADC) (523)
Approvals (17230)
Artificial intelligence (740)
ASCO (330)
Autoimmune disease (352)
Automation (64)
Bankruptcy (366)
Best Places to Work (11714)
BIO (71)
BIOSECURE Act (21)
Biosimilars (239)
Biotechnology (162)
Bladder cancer (205)
Brain cancer (75)
Breast cancer (808)
Cancer (6366)
Cardiovascular disease (517)
Career advice (1985)
Career pathing (46)
CAR-T (362)
CDC (62)
Celiac Disease (3)
Cell therapy (981)
Cervical cancer (56)
Clinical research (72124)
Collaboration (2228)
Commercialization (1)
Company closure (6)
Compensation (1502)
Complete response letters (97)
COVID-19 (2828)
CRISPR (119)
C-suite (1252)
Cystic fibrosis (159)
Data (8689)
Decentralized trials (3)
Denatured (31)
Depression (182)
Dermatology (98)
Diabetes (679)
Diagnostics (7116)
Digital health (64)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (367)
Drug pricing (221)
Drug shortages (35)
Duchenne muscular dystrophy (311)
Earnings (92473)
Editorial (75)
Employer branding (22)
Employer resources (162)
Events (121352)
Executive appointments (1142)
FDA (20848)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1868)
Gene editing (251)
Generative AI (63)
Gene therapy (765)
GLP-1 (1154)
Government (4870)
Grass and pollen (6)
Guidances (423)
Healthcare (19316)
Hematology (193)
HIV (91)
Huntington's disease (64)
IgA nephropathy (115)
Immunology and inflammation (320)
Immuno-oncology (110)
Indications (223)
Infectious disease (3200)
Inflammatory bowel disease (227)
Inflation Reduction Act (15)
Influenza (142)
Intellectual property (322)
Interviews (403)
IPO (16752)
IRA (53)
Job creations (3710)
Job search strategy (1628)
JPM (61)
Kidney cancer (23)
Labor market (116)
Layoffs (594)
Leadership (46)
Legal (8073)
Liver cancer (104)
Longevity (35)
Lung cancer (847)
Lymphoma (477)
Machine learning (66)
Management (64)
Manufacturing (1186)
Marketing (4)
MASH (212)
Medical affairs (1)
Medical device (14146)
Medtech (14319)
Mergers & acquisitions (20454)
Metabolic disorders (1709)
mRNA (240)
Multiple sclerosis (202)
NASH (18)
Neurodegenerative disease (479)
Neuropsychiatric disorders (117)
Neuroscience (3550)
Neurotech (1)
NextGen: Class of 2026 (6627)
Non-profit (4582)
Now hiring (83)
Obesity (799)
Opinion (330)
Ovarian cancer (241)
Pain (272)
Pancreatic cancer (357)
Parkinson's disease (398)
Partnered (36)
Patents (647)
Patient recruitment (778)
Peanut (68)
People (60339)
Pharmaceutical (54)
Pharmacy benefit managers (36)
Phase 1 (22427)
Phase 2 (31761)
Phase 3 (23695)
Pipeline (9930)
Policy (354)
Postmarket research (2624)
Preclinical (9544)
Press Release (64)
Prostate cancer (336)
Psychedelics (62)
Radiopharmaceuticals (347)
Rare diseases (1210)
Real estate (6021)
Recruiting (74)
Regulatory (26161)
Reports (60)
Research institute (2476)
Resumes & cover letters (395)
Rett syndrome (46)
RNA editing (26)
RSV (92)
Schizophrenia (185)
Series A (316)
Series B (233)
Service/supplier (11)
Sickle cell disease (122)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (49)
Startups (3702)
State (2)
Stomach cancer (19)
Supply chain (136)
Tariffs (95)
The Weekly (74)
Vaccines (1184)
Venture capital (124)
Weight loss (526)
Women's health (138)
Worklife (22)
Date
Today (91)
Last 7 days (499)
Last 30 days (2346)
Last 365 days (30638)
2026 (16496)
2025 (30421)
2024 (35433)
2023 (40322)
2022 (51458)
2021 (56020)
2020 (54493)
2019 (47041)
2018 (35439)
2017 (32494)
2016 (31920)
2015 (37938)
2014 (31712)
2013 (26701)
2012 (28981)
2011 (29612)
2010 (27717)
Location
Africa (795)
Alabama (93)
Alaska (7)
Arizona (371)
Arkansas (14)
Asia (40495)
Australia (6720)
California (14080)
Canada (3979)
China (1509)
Colorado (599)
Connecticut (615)
Delaware (434)
Europe (88106)
Florida (2121)
Georgia (449)
Hawaii (3)
Idaho (63)
Illinois (1159)
India (99)
Indiana (642)
Iowa (25)
Japan (601)
Kansas (134)
Kentucky (53)
Louisiana (58)
Maine (76)
Maryland (1674)
Massachusetts (10086)
Michigan (378)
Minnesota (764)
Mississippi (6)
Missouri (151)
Montana (33)
Nebraska (30)
Nevada (150)
New Hampshire (85)
New Jersey (3676)
New Mexico (31)
New York (3705)
North Carolina (1786)
North Dakota (9)
Northern California (7106)
Ohio (424)
Oklahoma (23)
Oregon (42)
Pennsylvania (2793)
Puerto Rico (32)
Rhode Island (52)
South America (1158)
South Carolina (87)
South Dakota (2)
Southern California (5587)
Tennessee (232)
Texas (2257)
United States (49670)
Utah (422)
Vermont (2)
Virginia (346)
Washington D.C. (82)
Washington State (1118)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
742,456 Results for "pressure point inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wiley and IQVIA Release Cross-Sector Report on AI’s Promise and Pressure Points Across Healthcare Value Chain
June 15, 2026
·
5 min read
Approvals
AstraZeneca wins nod for blood pressure pill, opening new class of hypertension drugs
Baxfendy, the first aldosterone synthase inhibitor to be approved by the FDA for high blood pressure, is among the products AstraZeneca is relying on to hit its 2030 goal of $80 billion in revenue.
May 18, 2026
·
1 min read
·
Tristan Manalac
Obesity
ADA: Metsera asset data support Pfizer’s ‘entry point’ into obesity market
Much work needs to be done for Pfizer to be able to catch up to the weight-loss frontrunners, according to Guggenheim Partners, but new data from Metsera’s lead asset could set the pharma apart from competitors with a monthly injection.
June 8, 2026
·
4 min read
·
Tristan Manalac
Press Releases
Co-Diagnostics Completes Clinical and Analytical Studies in Preparation for FDA 510(k) Submission of Upper Respiratory Point-of-Care Test
July 1, 2026
·
5 min read
Press Releases
CereVasc, Inc. Announces Over-Subscribed $85 Million Series C Financing to Advance its Novel eShunt® System for the Treatment of Normal Pressure Hydrocephalus
June 4, 2026
·
4 min read
Press Releases
Marius Pharmaceuticals Applauds FDA’s Proposed Testosterone Labeling Updates as a Turning Point for Men’s Health
June 22, 2026
·
4 min read
Press Releases
Huxley Medical Expands SANSA Diagnostic Platform with Point-of-Care Enrollment and Additional Cardiovascular Risk Marker
June 10, 2026
·
3 min read
Earnings
Novartis’ sales dip as generics pressure intensifies, radioequivalents loom
Executives insist Novartis will return to growth in the second half, but for Q1 2026, generic erosion drove a 5% drop in revenue, including a 46% nosedive for blockbuster heart failure drug Entresto.
April 28, 2026
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Kardigan Blood Pressure Drug Proves Hypothesis Despite Split Phase 2 Readout
While tonlamarsen missed one of two co-primary endpoints, Kardigan says the drug has shown a clinically meaningful effect on blood pressure, supporting advancement into Phase 2b.
March 30, 2026
·
2 min read
·
Annalee Armstrong
Complete response letters
Published FDA rejections point to manufacturing, data gaps as key stumbling blocks
The FDA’s decision last year to make complete response letters public provides new insight into why therapies sometimes fail to get the regulatory greenlight. Analysts say the information could help sponsors refine their regulatory strategies.
May 11, 2026
·
8 min read
·
Tristan Manalac
1 of 74,246
Next
